Growth Equity Opportunities Fund III LLC 13D and 13G filings for Strongbridge Biopharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-25 12:38 pm Sale | 2021-10-15 | 13D | Strongbridge Biopharma plc SBBP | Growth Equity Opportunities Fund III LLC | 0 0.000% | -4,141,308 (Position Closed) | Filing |